Since CHIP represents the first step on the path to leukemogenesis, it is also unsurprising that the same risk factors that predispose to MDS and AML (e.g. age, inflammation, DNA-damaging chemotherapies, and radiation) also promote the development and increase selective pressure for CHIP (24). This evidence concerns the gene STUB1 and myelodysplastic syndrome.